This study aims to identify patient characteristics associated with the development of Incontinence-Associated Dermatitis (IAD) category 2 (skin erosion due to incontinence). 380 ICU patients suffering of fecal incontinence will be included in the study. Data on 19 possible risk factors will be collected at one point in time by the research team. Different sources and methods will be used to collect patient data: skin assessment, patient record, direct patient observation, routine blood samples.
Incontinence is a widespread problem in all health care settings. Prevalence figures of incontinence vary around 20.0% of all hospitalized patients. In acute and critical care units the proportion of patients with fecal incontinence may rise up to 33.0%. One of the main complications of incontinence is inflammation of the skin in the genital and anal region, also known as incontinence-associated dermatitis (IAD). IAD is defined as skin inflammation manifested as redness with or without blistering, erosion, or loss of skin barrier function that occurs as a consequence of chronically or repeated exposure of the skin to urine or faeces. A range of skin care products and procedures for the prevention of IAD exists. In order to provide cost-effective IAD prevention, it's important to target preventive skin care interventions to patients at risk of IAD. The aims of this study are: 1. To identify specific factors associated with the development of Incontinence- Associated Dermatitis (IAD) in a recognized high risk patient population (ICU patients suffering from fecal incontinence) 2. To develop and statistically validate patient profiles being associated with high risk for IAD development This study is a matched case control study. The cases are defined as patients with IAD Cat. 2 (red skin with skin breakdown). The controls are defined as patients with IAD Cat. 0 (at risk, no redness and skin intact). The patient will be matched for fecal incontinence. In total, 380 ICU patients suffering from fecal incontinence will be included. 19 possible risk factors will be studied. All data will be collected at one point in time by the research team. Different sources and methods will be used to collect patient data: skin assessment, patient record, direct patient observation, routine blood samples. Specific IAD risk factors will be determined by applying univariate and multivariate binary logistic regression modeling.
Study Type
OBSERVATIONAL
Enrollment
206
Onze-Lieve-Vrouwziekenhuis Aalst
Aalst, Belgium
ZiekenhuisNetwerk Antwerpen
Antwerp, Belgium
AZ Monica
Deurne, Belgium
Ziekenhuis Oost-Limburg
Genk, Belgium
Algemeen Ziekenhuis Jan Palfijn
Ghent, Belgium
Algemeen Ziekenhuis Maria Middelares
Ghent, Belgium
AZ Sint-Lucas
Ghent, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Jessa Ziekenhuis
Hasselt, Belgium
Jan Yperman Ziekenhuis
Ieper, Belgium
...and 9 more locations
Acute Physiology and Chronic Health Evaluation score (APACHE II)
Time frame: 1 day
Presence of mechanical ventilation
Time frame: Up to six days
Presence of dialysis
Time frame: Up to six days
Presence of infection
Leucocyten count and white blood cell count
Time frame: Up to six days
Presence of fever
temperature \> 38.0°C
Time frame: Up to six days
Presence of inadequate arterial oxygen pressure
PaO2 \< 80mmHg
Time frame: Up to six days
Administration of antibiotics
Time frame: Up to six days
Administration of steroids
Time frame: Up to six days
Presence of malnutrition
Measured by serum albumin level
Time frame: Up to six days
Presence of diabetes
Time frame: Up to six days
Use of continence products (diapers, underpads)
Time frame: Up to six days
Use of washing without water (wipes, skin cleansers)
Time frame: Up to six days
Presence of urinary incontinence
Time frame: Up to six days
Presence of diarrhea
Measured by Bristol Stool Chart
Time frame: Up to six days
Presence of Clostridium difficile
Time frame: Up to six days
Presence of mechanical chafing
Time frame: Up to six days
Presence of low hemoglobin level
Time frame: Up to six days
Presence of enteral nutrition
Time frame: Up to six days
Presence of diminished cognitive awareness
Measured by Glasgow Coma Scale
Time frame: Up to six days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.